Publications by authors named "Outi Kuittinen"

55Publications

Impact of central nervous system (CNS) prophylaxis on the incidence of CNS relapse in patients with high-risk diffuse large B cell/follicular grade 3B lymphoma.

Ann Hematol 2020 Aug 23;99(8):1823-1831. Epub 2020 Jun 23.

Medical Research Center, Department of Oncology and Radiotherapy, Oulu University Hospital, University of Oulu, Kajaanintie 50, P.O. Box 5000, 900l4, Oulu, Finland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00277-020-04140-0DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7340636PMC
August 2020

Prognostic significance of Twist, ZEB1 and Slug in peripheral T-cell lymphomas.

Hematology 2020 Dec;25(1):241-246

Department of Oncology and Radiotherapy, Oulu University Hospital and University of Oulu, Oulu, Finland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/16078454.2020.1780754DOI Listing
December 2020

Thioredoxin-1 as a biological predictive marker for selecting diffuse large B-cell lymphoma patients for etoposide-containing treatment.

Eur J Haematol 2020 Aug 16;105(2):156-163. Epub 2020 Apr 16.

Department of Oncology, Faculty of Health Medicine, Institute of Clinical Medicine, Kuopio University Hospital, University of Eastern Finland, Kuopio, Finland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/ejh.13419DOI Listing
August 2020

Significance of bulky mass and residual tumor-Treated with or without consolidative radiotherapy-To the risk of relapse in DLBCL patients.

Cancer Med 2020 Mar 22;9(6):1966-1977. Epub 2020 Jan 22.

Faculty of Health Medicine, Department of Oncology, Institute of Clinical Medicine, Kuopio University Hospital, University of Eastern Finland, Oulu, Finland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/cam4.2798DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7064117PMC
March 2020

Peroxiredoxin 6 Serum Levels and Risk of Neutropenic Infections in Diffuse Large B-cell Lymphoma.

Anticancer Res 2019 Sep;39(9):4925-4931

Department of Oncology, Faculty of Health Medicine, Institute of Clinical Medicine, University of Eastern Finland, Kuopio, Finland.

View Article

Download full-text PDF

Source
http://ar.iiarjournals.org/lookup/doi/10.21873/anticanres.13
Publisher Site
http://dx.doi.org/10.21873/anticanres.13680DOI Listing
September 2019

Refractoriness to rituximab-based therapy and elevated serum B2-microglobulin predict for inferior survival in marginal zone lymphoma.

Leuk Lymphoma 2019 10 3;60(10):2524-2531. Epub 2019 Apr 3.

Department of Clinical Hematology, ICO-Hospital Germans Trias i Pujol. Institut de Recerca Josep Carreras, Universitat Autònoma de Barcelona , Badalona , Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/10428194.2019.1594212DOI Listing
October 2019

Treatment of diffuse large B-cell lymphoma in elderly patients: Replacing doxorubicin with either epirubicin or etoposide (VP-16).

Hematol Oncol 2019 Apr 18;37(2):136-142. Epub 2019 Jan 18.

Department of Oncology and Radiotherapy, Oulu University Hospital, Oulu, Finland.

View Article

Download full-text PDF

Source
http://doi.wiley.com/10.1002/hon.2572
Publisher Site
http://dx.doi.org/10.1002/hon.2572DOI Listing
April 2019

Case Report: Chemotherapy in Conjunction With Blood-Brain Barrier Disruption for a Patient With Germ Cell Tumor With Multiple Brain Metastases.

Clin Genitourin Cancer 2018 10 26;16(5):e993-e996. Epub 2018 May 26.

Department of Oncology, Medical Research Center, University of Oulu, Oulu University Hospital, Oulu, Finland.

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S15587673183037
Publisher Site
http://dx.doi.org/10.1016/j.clgc.2018.05.005DOI Listing
October 2018

Strong Prolyl Hydroxylase Domain 1 Expression Predicts Poor Outcome in Radiotherapy-treated Patients with Classical Hodgkin's Lymphoma.

Anticancer Res 2018 01;38(1):329-336

Department of Oncology and Radiotherapy, Medical Research Center Oulu, Oulu University Hospital, Oulu, Finland

View Article

Download full-text PDF

Source
http://dx.doi.org/10.21873/anticanres.12226DOI Listing
January 2018

Low Rap1-interacting factor 1 and sirtuin 6 expression predict poor outcome in radiotherapy-treated Hodgkin lymphoma patients.

Leuk Lymphoma 2018 03 8;59(3):679-689. Epub 2017 Aug 8.

a Department of Oncology and Radiotherapy , Medical Research Center Oulu, Oulu University Hospital and Cancer and Translational Medicine Research Unit, University of Oulu , Oulu , Finland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/10428194.2017.1344840DOI Listing
March 2018

Strong KDM4B and KDM4D Expression Associates with Radioresistance and Aggressive Phenotype in Classical Hodgkin Lymphoma.

Anticancer Res 2016 09;36(9):4677-83

Department of Oncology and Radiotherapy, Oulu University Hospital and University of Oulu, Oulu, Finland

View Article

Download full-text PDF

Source
http://dx.doi.org/10.21873/anticanres.11020DOI Listing
September 2016

Total peroxiredoxin expression is associated with survival in patients with follicular lymphoma.

Virchows Arch 2016 May 16;468(5):623-30. Epub 2016 Mar 16.

Department of Oncology and Radiotherapy, University of Oulu and Medical Research Center, Oulu University Hospital, P.O. Box 22, 90029, Oulu, Finland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00428-016-1920-2DOI Listing
May 2016

Antithrombin III is probably not a suitable biomarker for diagnosis of primary central nervous system lymphoma.

Ann Hematol 2015 Jul 21;94(7):1167-74. Epub 2015 Feb 21.

Department of Oncology and Radiotherapy, University of Oulu, Medical Research Center, and Oulu University Hospital, Kajaanintie 50, 90220, Oulu, Finland,

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00277-015-2334-yDOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4432105PMC
July 2015

Oxidative stress markers and mitochondrial antioxidant enzyme expression are increased in aggressive Hodgkin lymphomas.

Histopathology 2014 Sep 3;65(3):319-27. Epub 2014 Apr 3.

Department of Oncology and Radiotherapy, Oulu University Hospital and University of Oulu, Oulu, Finland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/his.12389DOI Listing
September 2014

Increased expression of CIP2A in aggressive subtypes of B-cell lymphoma.

Histopathology 2013 Sep 26;63(3):438-9. Epub 2013 Jun 26.

Department of Oncology and Radiotherapy, Oulu University Hospital, University of Oulu, Oulu, Finland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/his.12162DOI Listing
September 2013

Cell cycle regulation score predicts relapse-free survival in non-germinal centre diffuse large B-cell lymphoma patients treated by means of immunochemotherapy.

Eur J Haematol 2013 Jul 3;91(1):29-36. Epub 2013 May 3.

Department of Oncology and Radiotherapy, University of Oulu and Oulu University Hospital, Oulu, Finland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/ejh.12117DOI Listing
July 2013

Expression and prognostic evaluation of oxidative stress markers in an immunohistochemical study of B-cell derived lymphomas.

Leuk Lymphoma 2012 Apr 13;53(4):624-31. Epub 2011 Dec 13.

Department of Oncology and Radiotherapy, University of Oulu and Oulu University Hospital, Oulu, Finland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3109/10428194.2011.624226DOI Listing
April 2012

[Allogenic stem cell transplantations in lymphoma patients].

Duodecim 2010 ;126(2):167-73

KYS:n sisätautien klinikka, PL 1777, 70211 Kuopio.

View Article

Download full-text PDF

Source
May 2010

Neurolymphomatosis: an International Primary CNS Lymphoma Collaborative Group report.

Blood 2010 Jun 5;115(24):5005-11. Epub 2010 Apr 5.

Gaffin Center for Neuro-Oncology and Department of Hematology, Hadassah Hebrew University Medical Center, Jerusalem, Israel.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1182/blood-2009-12-258210DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3710441PMC
June 2010

Prognostic significance of p53 and matrix metalloproteinase-9 expression in follicular lymphoma.

Eur J Haematol 2008 Oct 8;81(4):289-97. Epub 2008 Jul 8.

Department of Oncology and Radiotherapy, University of Oulu and Oulu University Hospital, Oulu, Finland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/j.1600-0609.2008.01113.xDOI Listing
October 2008

Plasma MMP-2-TIMP-2 complex levels measured during follow-up predict a risk of relapse in patients with malignant lymphoma.

Eur J Haematol 2008 Jan 19;80(1):46-54. Epub 2007 Nov 19.

Department of Oncology and Radiotherapy, University of Oulu and Oulu University Hospital, Oulu, Finland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/j.1600-0609.2007.00975.xDOI Listing
January 2008

Clinicopathological correlations of TIMP-1 and TIMP-2 in Hodgkin's lymphoma.

Eur J Haematol 2004 Jan;72(1):1-9

Department of Oncology and Radiotherapy, Oulu University Hospital, Finland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1046/j.0902-4441.2004.00168.xDOI Listing
January 2004

Gelatinases (MMP-2 and MMP-9), TIMP-1 expression and the extent of neovascularization in aggressive non-Hodgkin's lymphomas.

Eur J Haematol 2003 Aug;71(2):91-9

Department of Oncology and Radiotherapy, Oulu University Hospital, Oulu, Finland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1034/j.1600-0609.2003.00101.xDOI Listing
August 2003

Diverse role of MMP-2 and MMP-9 in the clinicopathological behavior of Hodgkin's lymphoma.

Eur J Haematol 2002 Oct;69(4):205-12

Department of Oncology and Radiotherapy, Oulu University Hospital, Kajaanintie 50, 90220 Oulu, Finland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1034/j.1600-0609.2002.02751.xDOI Listing
October 2002

Autologous stem cell transplantation in patients with mantle cell lymphoma.

Leuk Lymphoma 2002 Jun;43(6):1229-37

Department of Medicine, Helsinki University Central Hospital, Finland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/10428190290026286DOI Listing
June 2002